BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 27422127)

  • 1. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.
    Joy A; Kapoor M; Georges J; Butler L; Chang Y; Li C; Crouch A; Smirnov I; Nakada M; Hepler J; Marty M; Feuerstein BG
    J Neurooncol; 2016 Oct; 130(1):43-52. PubMed ID: 27422127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans.
    Haslinger P; Haider S; Sonderegger S; Otten JV; Pollheimer J; Whitley G; Knöfler M
    Biol Reprod; 2013 Mar; 88(3):54. PubMed ID: 23303682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
    Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
    Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    Grottke A; Ewald F; Lange T; Nörz D; Herzberger C; Bach J; Grabinski N; Gräser L; Höppner F; Nashan B; Schumacher U; Jücker M
    PLoS One; 2016; 11(1):e0146370. PubMed ID: 26741489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
    Zitzmann K; Vlotides G; Brand S; Lahm H; Spöttl G; Göke B; Auernhammer CJ
    Endocr Relat Cancer; 2012 Jun; 19(3):423-34. PubMed ID: 22499437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.
    Turner KM; Sun Y; Ji P; Granberg KJ; Bernard B; Hu L; Cogdell DE; Zhou X; Yli-Harja O; Nykter M; Shmulevich I; Yung WK; Fuller GN; Zhang W
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3421-6. PubMed ID: 25737557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
    Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
    BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis.
    Hu B; Emdad L; Bacolod MD; Kegelman TP; Shen XN; Alzubi MA; Das SK; Sarkar D; Fisher PB
    Cancer Res; 2014 Dec; 74(24):7321-32. PubMed ID: 25304263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies.
    Dummler B; Tschopp O; Hynx D; Yang ZZ; Dirnhofer S; Hemmings BA
    Mol Cell Biol; 2006 Nov; 26(21):8042-51. PubMed ID: 16923958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt2 and Akt3 play a pivotal role in malignant gliomas.
    Mure H; Matsuzaki K; Kitazato KT; Mizobuchi Y; Kuwayama K; Kageji T; Nagahiro S
    Neuro Oncol; 2010 Mar; 12(3):221-32. PubMed ID: 20167810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions.
    Liu X; Shi Y; Birnbaum MJ; Ye K; De Jong R; Oltersdorf T; Giranda VL; Luo Y
    J Biol Chem; 2006 Oct; 281(42):31380-8. PubMed ID: 16923802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells.
    Girouard J; Lafleur MJ; Parent S; Leblanc V; Asselin E
    Gynecol Oncol; 2013 Feb; 128(2):335-43. PubMed ID: 23174537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All Akt isoforms (Akt1, Akt2, Akt3) are involved in normal hearing, but only Akt2 and Akt3 are involved in auditory hair cell survival in the mammalian inner ear.
    Brand Y; Levano S; Radojevic V; Naldi AM; Setz C; Ryan AF; Pak K; Hemmings BA; Bodmer D
    PLoS One; 2015; 10(3):e0121599. PubMed ID: 25811375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.
    Watson KL; Moorehead RA
    BMC Cancer; 2013 Aug; 13():375. PubMed ID: 23919516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines.
    Koseoglu S; Lu Z; Kumar C; Kirschmeier P; Zou J
    Cancer Biol Ther; 2007 May; 6(5):755-62. PubMed ID: 17426444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.
    Paul-Samojedny M; Pudełko A; Suchanek-Raif R; Kowalczyk M; Fila-Daniłow A; Borkowska P; Kowalski J
    Tumour Biol; 2015 May; 36(5):3263-77. PubMed ID: 25501707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function.
    Fortin SP; Ennis MJ; Savitch BA; Carpentieri D; McDonough WS; Winkles JA; Loftus JC; Kingsley C; Hostetter G; Tran NL
    Mol Cancer Res; 2009 Nov; 7(11):1871-81. PubMed ID: 19861406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.